15th Apr 2015 07:14
LONDON (Alliance News) - Shares in Omega Diagnostics Group PLC rose early Tuesday after the company said its results for its recently-ended financial year will be in line with market expectations.
The company expects revenue for the year to the end of March to be GBP12.1 million, up from GBP11.6 million a year earlier on the back of a 15% rise in revenue from its food intolerance business.
The medical diagnostics company said its adjusted pretax profit, before acquisition costs, share-based payments, IFRS-related discount unwinds and amortisation of intangible assets, will be GBP1.4 million, up from GBP1.1 million a year earlier, slightly ahead of its expectations.
Omega will publish its results for the year to the end of March on July 7.
Shares in the company were up 12% in early trade to 14.48 pence, one of the best performers in the AIM All-Share index.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
ODX.L